
Transcatheter Heart Valve Replacement and Repair Market Report and Forecast 2025-2034
Description
The global transcatheter heart valve replacement and repair market size was valued at USD 5.71 Billion in 2024, driven by the increasing prevalence of cardiovascular diseases across the globe. The market is expected to grow at a CAGR of 12.00% during the forecast period of 2025-2034, with the values likely to rise from USD 17.73 Billion by 2034.
Transcatheter Heart Valve Replacement and Repair: Introduction
Transcatheter aortic valve replacement and repair are procedures done to treat a stiff (calcified) or thickened aortic valve that cannot fully open (aortic stenosis). The aortic valve is located between left ventricle (lower heart chamber) and aorta (body's main artery). If this valve does not open properly, blood flow from heart to other parts is compromised and the heart is forced to work harder.
Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure that helps avoid the need for open heart surgery in a patient. TAVR can help a patient live a prolonged and comfortable life by restoring blood flow and reducing the symptoms of aortic valve stenosis like chest pain (angina) or tightness, shortness of breath, fluttering heartbeat (palpitations), an irregular heart sound (heart murmur) heard through a stethoscope, fainting and fatigue. Transcatheter aortic valve replacement (TAVR) is also called transcatheter aortic valve implantation (TAVI).
Global Transcatheter Heart Valve Replacement and Repair Market Analysis
Congenital heart defect is a major cause of aortic valve stenosis. It is the most common congenital disorder, responsible for about 28% of all congenital birth defects. In this defect, children are born with an aortic valve that has only two cusps instead of three. Children born with this defect require regular medical checkups. It may not cause any problems until adulthood but if the valve begins to narrow or leak, it may need to be repaired or replaced. With approximately 1.35 million babies born with CHD each year globally, the transcatheter heart valve replacement and repair market has experienced a parallel growth, driven by the increasing number of patients necessitating treatment.
Coronary artery calcification (CAC), which is highly prevalent in patients with coronary heart disease, grows with aging. By the time a person touches 70 or 80 years, calcium deposit starts on the valves. The stiffening valves need to be treated in time to avoid early demise. Hence, regions with increasing geriatric population are anticipated to observe a growth in the transcatheter heart valve replacement and repair market share.
Given the prevailing lifestyle characterized by obesity, high stress, blood pressure, and glucose levels, people are already at the risk of heart failures and open-heart surgeries. If such patterns persist, the prevalence of cardiovascular diseases is expected to escalate in the near future, potentially undergoing TAVR or TAVI to maintain a healthy life. As a result, there is a projected global expansion in the market size for transcatheter heart valve replacement and repair.
Global Transcatheter Heart Valve Replacement and Repair Market Segmentation
Transcatheter Heart Valve Replacement and Repair Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Procedure
There have been significant advancements in the field of cardiac sciences, despite the high prevalence of patients with some or the other form of cardiac disease. Medtronic's next-generation Evolut FX system is refined with gold markers built into the frame of the implant to visualise the implant depth and location better. Abbott's Portico with FlexNav TAVI System requires 76% less insertion force than their previous products. It is evident that the healthcare industry is growing to develop high-quality and innovative techniques to facilitate the procedures to precision.
Whether considering the highest number of cases or significant innovations, the North American region has been a focal point for the global transcatheter heart valve replacement and repair market development. Nonetheless, an anticipation of substantial demand is indicated towards the Asian region, primarily linked to its increasing emphasis on healthcare. The Asian territory constitutes to the maximum aging population globally. Hence, the prevalence of aortic stenosis and the cardiac surgical interventions are likely to increase, and the market size can expand in the future.
Global Transcatheter Heart Valve Replacement and Repair Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Transcatheter Heart Valve Replacement and Repair: Introduction
Transcatheter aortic valve replacement and repair are procedures done to treat a stiff (calcified) or thickened aortic valve that cannot fully open (aortic stenosis). The aortic valve is located between left ventricle (lower heart chamber) and aorta (body's main artery). If this valve does not open properly, blood flow from heart to other parts is compromised and the heart is forced to work harder.
Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure that helps avoid the need for open heart surgery in a patient. TAVR can help a patient live a prolonged and comfortable life by restoring blood flow and reducing the symptoms of aortic valve stenosis like chest pain (angina) or tightness, shortness of breath, fluttering heartbeat (palpitations), an irregular heart sound (heart murmur) heard through a stethoscope, fainting and fatigue. Transcatheter aortic valve replacement (TAVR) is also called transcatheter aortic valve implantation (TAVI).
Global Transcatheter Heart Valve Replacement and Repair Market Analysis
Congenital heart defect is a major cause of aortic valve stenosis. It is the most common congenital disorder, responsible for about 28% of all congenital birth defects. In this defect, children are born with an aortic valve that has only two cusps instead of three. Children born with this defect require regular medical checkups. It may not cause any problems until adulthood but if the valve begins to narrow or leak, it may need to be repaired or replaced. With approximately 1.35 million babies born with CHD each year globally, the transcatheter heart valve replacement and repair market has experienced a parallel growth, driven by the increasing number of patients necessitating treatment.
Coronary artery calcification (CAC), which is highly prevalent in patients with coronary heart disease, grows with aging. By the time a person touches 70 or 80 years, calcium deposit starts on the valves. The stiffening valves need to be treated in time to avoid early demise. Hence, regions with increasing geriatric population are anticipated to observe a growth in the transcatheter heart valve replacement and repair market share.
Given the prevailing lifestyle characterized by obesity, high stress, blood pressure, and glucose levels, people are already at the risk of heart failures and open-heart surgeries. If such patterns persist, the prevalence of cardiovascular diseases is expected to escalate in the near future, potentially undergoing TAVR or TAVI to maintain a healthy life. As a result, there is a projected global expansion in the market size for transcatheter heart valve replacement and repair.
Global Transcatheter Heart Valve Replacement and Repair Market Segmentation
Transcatheter Heart Valve Replacement and Repair Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Procedure
- Transcatheter Aortic Valve Replacement (TAVR)
- Transcatheter Mitral Valve Repair (TMVR)
- Transcatheter Pulmonary Valve Replacement (TPVR)
- Aortic Stenosis
- Mitral Regurgitation
- Aortic Regurgitation
- Mitral Stenosis
- Tricuspid Regurgitation
- Hospitals
- Cardiac Catheterization Laboratories
- Ambulatory Surgical Centres
- Others
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
There have been significant advancements in the field of cardiac sciences, despite the high prevalence of patients with some or the other form of cardiac disease. Medtronic's next-generation Evolut FX system is refined with gold markers built into the frame of the implant to visualise the implant depth and location better. Abbott's Portico with FlexNav TAVI System requires 76% less insertion force than their previous products. It is evident that the healthcare industry is growing to develop high-quality and innovative techniques to facilitate the procedures to precision.
Whether considering the highest number of cases or significant innovations, the North American region has been a focal point for the global transcatheter heart valve replacement and repair market development. Nonetheless, an anticipation of substantial demand is indicated towards the Asian region, primarily linked to its increasing emphasis on healthcare. The Asian territory constitutes to the maximum aging population globally. Hence, the prevalence of aortic stenosis and the cardiac surgical interventions are likely to increase, and the market size can expand in the future.
Global Transcatheter Heart Valve Replacement and Repair Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Edwards Lifesciences Corporation
- Medtronic
- Abbott
- Boston Scientific Corporation
- B. Braun SE
- MicroPort Scientific Corporation
- Meril Life Sciences Pvt. Ltd.
- Sahajanand Medical Technologies Limited
- Venus Medtech (Hangzhou) Inc.
- Peijia Medical Limited
- Blue Sail Medical Co Ltd
- Penumbra, Inc.
- Encapson
Table of Contents
350 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Transcatheter Heart Valve Replacement and Repair Market Overview
- 3.1 Global Transcatheter Heart Valve Replacement and Repair Market Historical Value (2018-2024)
- 3.2 Global Transcatheter Heart Valve Replacement and Repair Market Forecast Value (2025-2034)
- 4 Global Transcatheter Heart Valve Replacement and Repair Market Landscape
- 4.1 Global Transcatheter Heart Valve Replacement and Repair Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Global Transcatheter Heart Valve Replacement and Repair Product Landscape
- 4.2.1 Analysis by Procedure
- 4.2.2 Analysis by Indication
- 5 Global Transcatheter Heart Valve Replacement and Repair Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.3 Porter’s Five Forces Model
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Global Transcatheter Heart Valve Replacement and Repair Market Segmentation
- 6.1 Global Transcatheter Heart Valve Replacement and Repair Market by Procedure
- 6.1.1 Market Overview
- 6.1.2 Transcatheter Aortic Valve Replacement (TAVR)
- 6.1.3 Transcatheter Mitral Valve Repair (TMVR)
- 6.1.4 Transcatheter Pulmonary Valve Replacement (TPVR)
- 6.2 Global Transcatheter Heart Valve Replacement and Repair Market by Indication
- 6.2.1 Market Overview
- 6.2.2 Aortic Stenosis
- 6.2.3 Mitral Regurgitation
- 6.2.4 Aortic Regurgitation
- 6.2.5 Mitral Stenosis
- 6.2.6 Tricuspid Regurgitation
- 6.3 Global Transcatheter Heart Valve Replacement and Repair Market by End User
- 6.3.1 Market Overview
- 6.3.2 Hospitals
- 6.3.3 Cardiac Catheterization Laboratories
- 6.3.4 Ambulatory Surgical Centres
- 6.3.5 Others
- 6.4 Global Transcatheter Heart Valve Replacement and Repair Market by Region
- 6.4.1 Market Overview
- 6.4.2 North America
- 6.4.3 Europe
- 6.4.4 Asia Pacific
- 6.4.5 Latin America
- 6.4.6 Middle East and Africa
- 7 North America Transcatheter Heart Valve Replacement and Repair Market
- 7.1 Market Share by Country
- 7.2 United States of America
- 7.3 Canada
- 8 Europe Transcatheter Heart Valve Replacement and Repair Market
- 8.1 Market Share by Country
- 8.2 United Kingdom
- 8.3 Germany
- 8.4 France
- 8.5 Italy
- 8.6 Others
- 9 Asia Pacific Transcatheter Heart Valve Replacement and Repair Market
- 9.1 Market Share by Country
- 9.2 China
- 9.3 Japan
- 9.4 India
- 9.5 ASEAN
- 9.6 Australia
- 9.7 Others
- 10 Latin America Transcatheter Heart Valve Replacement and Repair Market
- 10.1 Market Share by Country
- 10.2 Brazil
- 10.3 Argentina
- 10.4 Mexico
- 10.5 Others
- 11 Middle East and Africa Transcatheter Heart Valve Replacement and Repair Market
- 11.1 Market Share by Country
- 11.2 Saudi Arabia
- 11.3 United Arab Emirates
- 11.4 Nigeria
- 11.5 South Africa
- 11.6 Others
- 12 Patent Analysis
- 12.1 Analysis by Type of Patent
- 12.2 Analysis by Publication year
- 12.3 Analysis by Issuing Authority
- 12.4 Analysis by Patent Age
- 12.5 Analysis by CPC Analysis
- 12.6 Analysis by Patent Valuation
- 12.7 Analysis by Key Players
- 13 Grants Analysis
- 13.1 Analysis by year
- 13.2 Analysis by Amount Awarded
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Grant Application
- 13.5 Analysis by Funding Institute
- 13.6 Analysis by NIH Departments
- 13.7 Analysis by Recipient Organization
- 14 Funding Analysis
- 14.1 Analysis by Funding Instances
- 14.2 Analysis by Type of Funding
- 14.3 Analysis by Funding Amount
- 14.4 Analysis by Leading Players
- 14.5 Analysis by Leading Investors
- 14.6 Analysis by Geography
- 15 Partnership and Collaborations Analysis
- 15.1 Analysis by Partnership Instances
- 15.2 Analysis by Type of Partnership
- 15.3 Analysis by Leading Players
- 15.4 Analysis by Geography
- 16 Regulatory Framework
- 16.1 Regulatory Overview
- 16.1.1 US FDA
- 16.1.2 EU EMA
- 16.1.3 INDIA CDSCO
- 16.1.4 JAPAN PMDA
- 16.1.5 Others
- 17 Supplier Landscape
- 17.1 Edwards Lifesciences Corporation
- 17.1.1 Financial Analysis
- 17.1.2 Product Portfolio
- 17.1.3 Demographic Reach and Achievements
- 17.1.4 Mergers and Acquisitions
- 17.1.5 Certifications
- 17.2 Medtronic
- 17.2.1 Financial Analysis
- 17.2.2 Product Portfolio
- 17.2.3 Demographic Reach and Achievements
- 17.2.4 Mergers and Acquisitions
- 17.2.5 Certifications
- 17.3 Abbott
- 17.3.1 Financial Analysis
- 17.3.2 Product Portfolio
- 17.3.3 Demographic Reach and Achievements
- 17.3.4 Mergers and Acquisitions
- 17.3.5 Certifications
- 17.4 Boston Scientific Corporation
- 17.4.1 Financial Analysis
- 17.4.2 Financial Portfolio
- 17.4.3 Demographic Reach and Achievements
- 17.4.4 Mergers and Acquisitions
- 17.4.5 Certifications
- 17.5 B. Braun SE
- 17.5.1 Financial Analysis
- 17.5.2 Product Portfolio
- 17.5.3 Demographic Reach and Achievements
- 17.5.4 Mergers and Acquisitions
- 17.5.5 Certifications
- 17.6 MicroPort Scientific Corporation
- 17.6.1 Financial Analysis
- 17.6.2 Product Portfolio
- 17.6.3 Demographic Reach and Achievements
- 17.6.4 Mergers and Acquisitions
- 17.6.5 Certifications
- 17.7 Meril Life Sciences Pvt. Ltd.
- 17.7.1 Financial Analysis
- 17.7.2 Product Portfolio
- 17.7.3 Demographic Reach and Achievements
- 17.7.4 Mergers and Acquisitions
- 17.7.5 Certifications
- 17.8 Sahajanand Medical Technologies Limited
- 17.8.1 Financial Analysis
- 17.8.2 Product Portfolio
- 17.8.3 Demographic Reach and Achievements
- 17.8.4 Mergers and Acquisitions
- 17.8.5 Certifications
- 17.9 Venus Medtech (Hangzhou) Inc.
- 17.9.1 Financial Analysis
- 17.9.2 Product Portfolio
- 17.9.3 Demographic Reach and Achievements
- 17.9.4 Mergers and Acquisitions
- 17.9.5 Certifications
- 17.10 Peijia Medical Limited
- 17.10.1 Financial Analysis
- 17.10.2 Product Portfolio
- 17.10.3 Demographic Reach and Achievements
- 17.10.4 Mergers and Acquisitions
- 17.10.5 Certifications
- 17.11 Blue Sail Medical Co Ltd
- 17.11.1 Financial Analysis
- 17.11.2 Product Portfolio
- 17.11.3 Demographic Reach and Achievements
- 17.11.4 Mergers and Acquisitions
- 17.11.5 Certifications
- 17.12 Penumbra, Inc.
- 17.12.1 Financial Analysis
- 17.12.2 Product Portfolio
- 17.12.3 Demographic Reach and Achievements
- 17.12.4 Mergers and Acquisitions
- 17.12.5 Certifications
- 17.13 Encapson
- 17.13.1 Financial Analysis
- 17.13.2 Product Portfolio
- 17.13.3 Demographic Reach and Achievements
- 17.13.4 Mergers and Acquisitions
- 17.13.5 Certifications
- 18 Global Transcatheter Heart Valve Replacement and Repair Market - Distribution Model (Additional Insight)
- 18.1 Overview
- 18.2 Potential Distributors
- 18.3 Key Parameters for Distribution Partner Assessment
- 19 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 20 Company Competitiveness Analysis (Additional Insight)
- 20.1 Very Small Companies
- 20.2 Small Companies
- 20.3 Mid-Sized Companies
- 20.4 Large Companies
- 20.5 Very Large Companies
- 21 Payment Methods (Additional Insight)
- 21.1 Government Funded
- 21.2 Private Insurance
- 21.3 Out-of-Pocket
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.